EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Author(s):
Taphoorn, M.J.B.; Dirven, L.; Taillibert, S.; Honnorat, J.; Chen, T.; Sroubek, J.; Paek, S.H.; Escuder, J.B.; Easaw, J.C.; David, C.A.; Kim, C.Y.; Desai, R.D.; Kew, Y.; Olivi, A.; Nicholas, G.A.; Lavy-Shahaf, G.; Kirson, E.D.; Ram, Z.; Stupp, R.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-11-30
Language
English
Is part of
Neuro-Oncology (2017), Vol. 19, p. 206-206
hdl
1887/95819